CO2022015823A2 - Derivados de n-(piperidin-4-il)benzamida de acción luminal - Google Patents
Derivados de n-(piperidin-4-il)benzamida de acción luminalInfo
- Publication number
- CO2022015823A2 CO2022015823A2 CONC2022/0015823A CO2022015823A CO2022015823A2 CO 2022015823 A2 CO2022015823 A2 CO 2022015823A2 CO 2022015823 A CO2022015823 A CO 2022015823A CO 2022015823 A2 CO2022015823 A2 CO 2022015823A2
- Authority
- CO
- Colombia
- Prior art keywords
- luminal
- piperidin
- acting
- benzamide derivatives
- compounds
- Prior art date
Links
- JMQDNLCNCDSHNC-UHFFFAOYSA-N n-piperidin-4-ylbenzamide Chemical class C=1C=CC=CC=1C(=O)NC1CCNCC1 JMQDNLCNCDSHNC-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 108091005482 5-HT4 receptors Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se describen compuestos de Fórmula 1, , y sales farmacéuticamente aceptables de estos, en donde m, R1, R2, R3, R4, R5, R6, X1, X2, X3 y X4 se definen en la memoria descriptiva. Esta descripción también hace referencia a materiales y métodos para la preparación de compuestos de Fórmula 1, a composiciones farmacéuticas que los contienen y a su uso para el tratamiento de enfermedades, trastornos y afecciones asociados con el receptor 5-HT4.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063019829P | 2020-05-04 | 2020-05-04 | |
PCT/US2021/030493 WO2021225968A1 (en) | 2020-05-04 | 2021-05-03 | Luminally-acting n-(piperidin-4-yl)benzamide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2022015823A2 true CO2022015823A2 (es) | 2022-11-18 |
Family
ID=76060006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2022/0015823A CO2022015823A2 (es) | 2020-05-04 | 2022-11-02 | Derivados de n-(piperidin-4-il)benzamida de acción luminal |
Country Status (17)
Country | Link |
---|---|
US (1) | US20230158010A1 (es) |
EP (1) | EP4146625A1 (es) |
JP (1) | JP2023525986A (es) |
KR (1) | KR20230005893A (es) |
CN (1) | CN115515933A (es) |
AR (1) | AR122005A1 (es) |
AU (1) | AU2021266690A1 (es) |
BR (1) | BR112022022184A2 (es) |
CA (1) | CA3182379A1 (es) |
CL (1) | CL2022003067A1 (es) |
CO (1) | CO2022015823A2 (es) |
EC (1) | ECSP22091230A (es) |
IL (1) | IL297456A (es) |
MX (1) | MX2022013745A (es) |
PE (1) | PE20231375A1 (es) |
TW (1) | TW202208333A (es) |
WO (1) | WO2021225968A1 (es) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
GB9518953D0 (en) | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
KR100976063B1 (ko) * | 2007-03-16 | 2010-08-17 | 동아제약주식회사 | 신규한 벤즈아미드 유도체 화합물 및 그의 제조방법 |
KR20100026641A (ko) * | 2008-09-01 | 2010-03-10 | 동아제약주식회사 | 신규한 벤즈아미드 유도체 화합물 및 그의 제조방법 |
-
2021
- 2021-05-03 BR BR112022022184A patent/BR112022022184A2/pt unknown
- 2021-05-03 EP EP21727329.1A patent/EP4146625A1/en active Pending
- 2021-05-03 US US17/923,183 patent/US20230158010A1/en active Pending
- 2021-05-03 WO PCT/US2021/030493 patent/WO2021225968A1/en active Application Filing
- 2021-05-03 CA CA3182379A patent/CA3182379A1/en active Pending
- 2021-05-03 PE PE2022002548A patent/PE20231375A1/es unknown
- 2021-05-03 MX MX2022013745A patent/MX2022013745A/es unknown
- 2021-05-03 JP JP2022567186A patent/JP2023525986A/ja active Pending
- 2021-05-03 CN CN202180033067.3A patent/CN115515933A/zh active Pending
- 2021-05-03 IL IL297456A patent/IL297456A/en unknown
- 2021-05-03 AU AU2021266690A patent/AU2021266690A1/en active Pending
- 2021-05-03 KR KR1020227040506A patent/KR20230005893A/ko active Search and Examination
- 2021-05-04 AR ARP210101213A patent/AR122005A1/es unknown
- 2021-05-04 TW TW110116059A patent/TW202208333A/zh unknown
-
2022
- 2022-11-02 CO CONC2022/0015823A patent/CO2022015823A2/es unknown
- 2022-11-04 CL CL2022003067A patent/CL2022003067A1/es unknown
- 2022-11-28 EC ECSENADI202291230A patent/ECSP22091230A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA3182379A1 (en) | 2021-11-11 |
BR112022022184A2 (pt) | 2023-01-17 |
AR122005A1 (es) | 2022-08-03 |
CL2022003067A1 (es) | 2023-07-14 |
WO2021225968A1 (en) | 2021-11-11 |
MX2022013745A (es) | 2022-11-16 |
TW202208333A (zh) | 2022-03-01 |
JP2023525986A (ja) | 2023-06-20 |
CN115515933A (zh) | 2022-12-23 |
AU2021266690A1 (en) | 2022-11-10 |
US20230158010A1 (en) | 2023-05-25 |
PE20231375A1 (es) | 2023-09-07 |
IL297456A (en) | 2022-12-01 |
ECSP22091230A (es) | 2023-02-28 |
KR20230005893A (ko) | 2023-01-10 |
EP4146625A1 (en) | 2023-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR030959A1 (es) | Derivados de aminoalcoholes, procedimiento para prepararlos, el uso de los mismos para preparar medicamentos y las composiciones farmaceuticas que las contienen | |
UY31468A1 (es) | Derivados bis-(sulfonilamino) en terapia 065 | |
ECSP10010178A (es) | Derivados bis-(sulfonilamino) en terapia 066 | |
UY31546A1 (es) | Derivados bis-(sulfonilamino) en terapia 205 | |
PA8575401A1 (es) | Derivados de heteroarilamida benzocondensada de tienopiridinas utiles como agentes terapeuticos, composiciones farmaceuticas que incluyen a los mismos y metrodos para su uso | |
UY29825A1 (es) | Derivados sustituidos de 3h-imidazol-(4,5 b (beta))piridina-2-il benzoatos y benzamidas, composiciones farmacéuticas que los contienen y aplicaciones | |
GT199800180A (es) | Derivados de la tienopirimidina y de la tienopiridina utiles como agentes anticancerigenos. | |
UY27336A1 (es) | Derivados de 4-piperacinilindol con afinidad receptora de 5-ht6 | |
AR032361A1 (es) | Derivados de androstano y sales y solvatos de los mismos, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que comprenden tales compuestos, proceso para la preparacion de dichos compuestos, e intermediarios utiles en la preparacion de tales compuestos | |
DOP2022000057A (es) | Derivados de piridazin-3(2h)-ona fusionados con azol | |
ECSP20062464A (es) | Piperidinil-3-(ariloxi)propanamidas y propanoatos | |
AR058180A1 (es) | Indeno derivados, su preparacion y su uso como medicamentos | |
AR067779A1 (es) | Profarmacos dipeptoides y su uso | |
AR035153A1 (es) | Derivados de carboxamidas y cetonas de dihidrobenzodioxina | |
ECSP21080966A (es) | Derivados de 1,1-dióxido de 3-amino-4h-benzo[e][1,2,4] tiadiazina como inhibidores de mrgx2 | |
CL2022003646A1 (es) | Derivados de amidopirimidona | |
AR127050A1 (es) | Compuestos espirocíclicos | |
AR045156A1 (es) | Derivados de 5-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos | |
ECSP22049160A (es) | Derivados de bencimidazol | |
CL2022002386A1 (es) | Compuestos de amino pirimidina fusionados | |
CL2022003000A1 (es) | Compuestos útiles para inhibir la quinasa ret | |
CO2022015823A2 (es) | Derivados de n-(piperidin-4-il)benzamida de acción luminal | |
CO2023000117A2 (es) | Derivados de sulfona | |
ECSP22082217A (es) | Derivados de n-heteroarilalquil-2-(heterociclil y heterociclilmetil)acetamida | |
AR124720A1 (es) | Derivados de pirazolamida |